Welcome, Guest. Please login or register.
July 13, 2024, 11:57:34 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 103
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 36
Total: 36


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Broadly Testing, Treating Hep C in Prisons Is a Good Value  (Read 5519 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Broadly Testing, Treating Hep C in Prisons Is a Good Value
« on: September 04, 2019, 11:04:07 am »
A broad-based program to test for and treat hepatitis C virus (HCV) among those who pass through U.S. prisons would be cost effective at current drug prices but would nevertheless place a considerable financial burden on prison budgets.

Perhaps one in three U.S. residents living with hep C are inmates in a U.S. prison during any given year.

Publishing their findings in Clinical Infectious Diseases, researchers used mathematical modeling informed by published data and Washington State Department of Corrections individual-level data to project the impact of various strategies for approaching hep C testing, treatment and post-release linkage to medical care among inmates.



© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.